Hat glasses for eye protection during jaundice light therapy
Part of Genetic & congenital clinical trials.
This trial tests a special hat-like glasses to protect babies' eyes during phototherapy (light treatment for jaundice). It is for healthy full-term newborns who are in a regular hospital room.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be a full-term newborn (born between 38 and 42 weeks).
- Your baby's Apgar score at birth must be 7, 8, 9, or 10 (a healthy score).
- Your baby must be staying in a regular hospital room and in a standard crib.
- Your baby cannot have a serious (pathological) form of jaundice.
- Your baby must not have any birth defects or congenital anomalies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This study looks at how hospitals decide when to start treatment for jaundice (a yellowing of the skin) in very premature babies. The aim is to find the safest and most effective way to use bilirubin levels to guide care and improve outcomes for your baby.
This study is looking at a new scoring system to help doctors quickly tell how severe jaundice is in newborns. The goal is to better decide when a baby needs stronger treatment like a blood exchange, so the right care can be given sooner.
This study tests a device that measures jaundice level through the skin without needing a blood test. It is for newborns who need light therapy.
This study looks for a safe threshold to stop the “light therapy” (phototherapy) in newborns who have jaundice caused by blood cell breakdown (hemolytic disease). It may help some babies avoid unnecessary extra days of treatment while still staying safe.
Hear when a new Neonatal Hyperbilirubinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.